Silymarin in COVID-19 Pneumonia
NCT04394208
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Viral Pneumonia Human Coronavirus
Interventions
DRUG:
Silymarin
DRUG:
Placebo
Sponsor
Cairo University